Company Overview and News

Oil and gas sector jittery about immediate impact of move away from fossil fuels

While New Zealand's government said a transition away from fossil fuels will take several decades, concern about the immediate future is running high in the sector given investment already sunk into exploration.
Upvote Downvote

Zeta to increase stake in GME

Zeta Resources is set to increase its position in Perth-based nickel company GME Resources to nearly 50 per cent following the acquisition of investment firm Axelrock for $50.1 million.
Upvote Downvote

Zeta buys Axelrock for $50m: ups stakes in GME, Alliance, Seacrest

Investment company Zeta Resources has announced it is to purchase Axelrock, a move that will sizeably increasing its stake in three of holding company Axelrock’s subsidiaries: GME Resources (nickel-cobalt), Alliance Mining (gold and base metals) and Seacrest LP (oil and gas).
Upvote Downvote

NZOG shareholders question OG offer

New Zealand Oil and Gas shareholders had mixed views on the partial takeover offer from OG offer at the company's annual meeting in Wellington this morning.
Upvote Downvote

Ofer Global Oil & Gas extends takeover offer for NZ Oil & Gas by a month

OG Oil & Gas has extended the closing date of its partial takeover bid for New Zealand Oil & Gas by one month to December 9, while shareholder H&G has tendered its entire 9.2 per cent stake into the offer.
Upvote Downvote

Zeta Resources bid for NZ Oil & Gas fails, H&G plans to accept Ofer Group Oil & Gas' offer

Private investment firm H&G will accept Ofer Group Oil & Gas' offer for New Zealand Oil & Gas after ASX-listed Zeta Resources' play to seize control of the company did not meet the minimum acceptance condition and has lapsed.
Upvote Downvote

Panoramic Resources - The Lady Is A Tramp?

2017-10-18 seekingalpha
Savannah Mine has a minimum life time of 8.5 years with 11,000t Ni, 5,800t Cu, 760t Co output p.a.).
Upvote Downvote

NZX50 cracks 8,000, led by market darlings A2, Xero

New Zealand shares rose, with the benchmark index surpassing 8,000 for the first time, led higher by export-orientated, investor favourites A2 Milk Co and Xero.
Upvote Downvote

OGOG wins NZOG's blessing after lifting offer by 1 cent a share

OG Oil & Gas has sweetened its partial takeover bid for New Zealand Oil & Gas, winning over the Kiwi energy explorer's independent directors.
Upvote Downvote

Synlait success has stock at record high

New Zealand shares inched up, with Synlait Milk touching records, A2 Milk gaining after Synlait's positive earnings and New Zealand Refining recovering.
Upvote Downvote

OG Oil & Gas keen on NZX-listing for NZOG in partial bid to keep future capital lines open

OG Oil & Gas, the oil and gas division of Ofer Global Group, is pursuing a partial takeover of New Zealand Oil & Gas to keep the local energy explorer's NZX listing and the access to future capital it provides.
Upvote Downvote

Kuwait officials say oil spill controlled

2017-08-14 ogj
The source of an oil spill off southern Kuwait remained undetermined Aug. 14 as officials said floating oil had been contained and clean-up was in progress.
Upvote Downvote

ESAI 5-year oil outlook sees tenuous balance

2017-08-14 ogj
In its recent Five-Year Outlook, ESAI Energy points out that the call on Organization of Petroleum Exporting Countries crude will remain under tremendous pressure over the next 5 years.  
Upvote Downvote

MARKET WATCH: Oil prices end week with gain on IEA revisions - Oil & Gas Journal

2017-08-14 ogj
US light, sweet crude prices gained slightly on Aug. 11 but settled below $49/bbl and ended the week down 1.53%—the second consecutive weekly decline. At its highest point last week, the US benchmark briefly topped $50/bbl on Aug. 10 but settled well below that.
Upvote Downvote

Zeta makes partial takeover bid for New Zealand Oil & Gas

2017-08-11 ogj
Singapore-based Zeta Energy Pte. Ltd., a wholly owned subsidiary of investment group Zeta Resources Ltd., has launched a partial offer for Wellington-based New Zealand Oil & Gas Ltd. (NZOG). If successful, Zeta would gain a 50.1% controlling interest in NZOG.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...